Skip to main content
Erschienen in: Gastric Cancer 4/2013

01.10.2013 | Original Article

Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis

verfasst von: Sho Takahashi, Michiaki Hirayama, Ganji Kuroiwa, Yutaka Kawano, Kohichi Takada, Tsutomu Sato, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Masayoshi Kobune, Junji Kato

Erschienen in: Gastric Cancer | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

This retrospective study was carried out to compare computed tomographic (CT) gastrography and conventional optical gastroscopy (GS) in order to evaluate the effectiveness of chemotherapy in primary gastric lesions.

Methods

Patients with unresectable advanced and unresected early gastric cancer who had primary lesions and had received chemotherapy were enrolled. For primary lesions, CT gastrography and endoscopic assessment were done after chemotherapy, based on the Japanese Classification of Gastric Carcinoma (JCGC) criteria, 13th edition, and the Response Evaluation Criteria in Solid Tumors (RECIST). For metastatic solid lesions including lymph nodes, CT assessment was done based on the RECIST criteria.

Results

Data from 23 patients were analyzed. With median follow-up of 9.4 months (range 2–23 months), 58 examinations were assessed by GS and CT gastrography. Setting optical endoscopic results as the gold standard, the accuracy of CT gastrography for primary gastric lesions was 77.6 % (45 of 58) (weighted κ = 0.72; P < 0.01) according to the JCGC 13th edition criteria and 90.0 % (52 of 58) (weighted κ = 0.75; P < 0.01) according to the RECIST. When all results were divided into two groups [the non-progressive disease (non-PD) group and PD group], accuracy was 93.1 % (52 of 58) (κ = 0.81; P < 0.01), sensitivity was 100 %, and specificity was 75.0 % (12 of 16). In addition, the predictability of PD was 100 % (12 of 12). The four cases of failure in specification were the following: a case of gastric remnant cancer, a case with insufficient distension of the stomach, a healed case with stenosis and scarring, and a case in which the wrong position had been selected for the examination. The average period until PD was 9.9 months (range 5–18 months), and the concordance period between GS and CT gastrography was 7.2 months in both non-PD and PD cases.

Conclusions

There was good concordance between the evaluations of GS and CT gastrography. CT gastrography exhibited favorable results in accuracy as well as 100 % PD predictability, which implied the possibility of using CT gastrography as a substitute for endoscopic assessments at post-chemotherapy assessments.
Literatur
1.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 14th edition. Tokyo: Kanehara; 2010. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 14th edition. Tokyo: Kanehara; 2010.
2.
Zurück zum Zitat Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–4. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–4.
3.
Zurück zum Zitat Kiyohashi A, Kurihara M, Yoshida S, Ohkubo T, Suga S. Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer. Jpn J Clin Oncol. 1993;23:41–5.PubMed Kiyohashi A, Kurihara M, Yoshida S, Ohkubo T, Suga S. Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer. Jpn J Clin Oncol. 1993;23:41–5.PubMed
4.
Zurück zum Zitat Ohtsu A, Boku N, Yoshida S, Miyata Y, Shirao K, Shimada Y, et al. Response of the primary lesion in gastric cancer to chemotherapeutic trials. Int J Clin Oncol. 1998;3:3–6.CrossRef Ohtsu A, Boku N, Yoshida S, Miyata Y, Shirao K, Shimada Y, et al. Response of the primary lesion in gastric cancer to chemotherapeutic trials. Int J Clin Oncol. 1998;3:3–6.CrossRef
5.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 13th edition. Tokyo: Kanehara; 1999. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 13th edition. Tokyo: Kanehara; 1999.
6.
7.
Zurück zum Zitat Ogata I, Komohara Y, Yamashita Y, Mitsuzaki K, Takahashi M, Ogawa M. CT evaluation of gastric lesions with three-dimensional display and interactive virtual endoscopy: comparison with conventional barium study and endoscopy. AJR. 1999;172:1263–70.PubMedCrossRef Ogata I, Komohara Y, Yamashita Y, Mitsuzaki K, Takahashi M, Ogawa M. CT evaluation of gastric lesions with three-dimensional display and interactive virtual endoscopy: comparison with conventional barium study and endoscopy. AJR. 1999;172:1263–70.PubMedCrossRef
8.
Zurück zum Zitat Inamoto K, Kouzai K, Ueeda T, Marukawa T. CT virtual endoscopy of the stomach: comparison study with gastric fiberscopy. Abdom Imaging. 2005;30:473–9.PubMedCrossRef Inamoto K, Kouzai K, Ueeda T, Marukawa T. CT virtual endoscopy of the stomach: comparison study with gastric fiberscopy. Abdom Imaging. 2005;30:473–9.PubMedCrossRef
9.
Zurück zum Zitat Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215–21.PubMedCrossRef Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215–21.PubMedCrossRef
Metadaten
Titel
Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis
verfasst von
Sho Takahashi
Michiaki Hirayama
Ganji Kuroiwa
Yutaka Kawano
Kohichi Takada
Tsutomu Sato
Koji Miyanishi
Yasushi Sato
Rishu Takimoto
Masayoshi Kobune
Junji Kato
Publikationsdatum
01.10.2013
Verlag
Springer Japan
Erschienen in
Gastric Cancer / Ausgabe 4/2013
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-012-0217-7

Weitere Artikel der Ausgabe 4/2013

Gastric Cancer 4/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.